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Many inhibitory and toxic effects show
a dose dependence for which the extrapola-
tion of a linear plot to zero or background
effect cuts through the abscissa at some
positive dose, indicating a threshold concen-
tration below which the agent seems to be
ineffective (1). If the teratogenic effect of
such an agent is caused by the same cellular
reaction, its dose-effect curve may also ex-
hibit a threshold, though with a lower value.
In contrast, for most mutagenic compounds
a linear plot of the frequency of induced
mutations against the dose (concentration)
has exhibited no threshold; such experi-
ments were done with transforming DNA
or bacterial viruses (2-4), bacteria or fungi
(5, 6), plants (7-9, Sparrow and Scheirer,
personal communication), insects (10), and
mammalian test systems (11, 12). An ap-
parent threshold of mutation induction has
been observed only rarely, usually where
the investigated cells could be reached only
after the mutagen had passed several bar-
riers (12, 13). One may therefore ask
whether there are fundamental reasons for
this different dose response of toxic versus
mutagenic effects and under which condi-
tions a threshold effect could be expected.
Such considerations are important for the
experimental evaluation of the potential
hazard of pesticides, drugs, or food additives.
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Before this problem is examined, a few
words are needed concerning the extrapola-
tion of experimental data. Such data can
always be plotted in a number of ways, e.g.,
linearly against the dose, against some power
of the dose, or against the logarithm of
the dose (as is usually done for toxic com-
pounds with very different potencies). To
demonstrate its increase with some power of
the dose, one can also plot the logarithm of
the effect against the logarithm of the dose.
While any of these plots can be used to
display experimental points, an extrapola-
tion of such points to lower dose values is
justified only if there are good theoretical
reasons to assume a particular dose depend-
ence (linear, square, etc.). In many experi-
mental systems, especially in simple micro-
bial tests, there are good chemical reasons
to assume that the effect at low doses in-
creases linearly with (or with the square
of) the dose, and the experimental data
have verified this assumption wherever it
was tested extensively (2, 3); a straight-
line extrapolation of a linear plot (or a plot
against the square of the dose) is then justi-
fied. However, if no such assumptions are
warranted, the following approach seems
the only one justified. After making as many
measurements as feasible, one calculates for
various possible dose-effect curves (e.g.,
polynomials with unknown coefficients and
exponents), the best least-square approxi-
mation of all the experimental points (with
different weights if warranted), and the
mean-square deviation from the calculated
December 1973 171curve (such calculations are simple and fast
if modern computer programs are used).
At this stage, one can either assume that
the curve with the lowest mean-square
deviation represents the correct curve, or
one can still insert a theoretical bias to
select out of several curves -with similar
mean-square deviations the-.on. which ap-
pears most likely correct.--Although this
approach is not as precise as. obtaining more
data, it certainly is more satisfactory than
the guesses often used in the interpretation
of experimental data. A thorough statistical
evaluation of such data is the-more valuable
the more complex the biological system,
because the time needed for analysis repre-
sents a progressively smaller fraction of the
time needed to acquire additional data at
lower dose levels. Unfortunately, experimen-
tal data are often too sparse to allow any
statistical curve fitting.
Toxic Effects
Most toxic compounds or other agents in
commercial or medical use inhibit cellular
reactions reversibly, some inhibit irrevers-
ibly, and few kill individual cells.
Reversible inhibition may affect, e.g., an
enzyme or the transport mechanism of the
cell. It is subject to the mass action laws
summarized by the Michaelis-Menton equa-
tion (1).
If the inhibited reaction is rate-limiting,
the extent of inhibition I is described by:
I =(1) I (c + k)
where c is the concentration of compound
and k is a constant. When I is plotted
against c, the curve increases linearly from
the zero point and saturates at the value
1 (100% inhibition). When I is plotted
against the logarithm of c, a sigmoid curve
is obtained. Such semilogarithmic plots
are frequently used for the comparison of
drugs with different potency. (One might
be tempted to extrapolate the curve through
the experimental points of a semilogarith-
mic plot to some positive concentration value
on the abscissa, especially since the statis-
tical variation of values determined at lower
drug concentrations is high. Thus one might
erroneously conclude the existence of a
threshold. As explained above, an extra-
polation of such inhibition data is justified
only for a linear plot of the experimental
values.)
A true threshold of the observable biologi-
cal effect may exist if the inhibited reaction
does not normally limit the rate of cell
metabolism or of an organ's function. In
that case, no biological effect will be observed
until the inhibitor concentration has ex-
ceeded a certain minimal (or threshold)
value T. The inhibition equation then takes
the form:
I (c - T)
(c + K) (2)
Zero inhibition is obtained when c = T.
The curves described by eq, (2) are the
same as for eq, (1), except that they are
shifted along the abscissa by the value T (if
K = k- T).
For slowly reversible or irreversible in-
hibition the situation is similar, but the
equations become more complex and in the
case of irreversible inhibitors cannot be ex-
plained by the Michaelis-Menton theory (1).
Again, a threshold value may exist if the
inhibited reaction is not rate limiting.
A toxic effect may also result from the
killing of a number of cells in a multicellular
organism. Cell death is most generally de-
fined by the inability of the cell to multiply.
It can be caused by the cumulative effect of
inhibitor molecules, leading to the leakage
of the cell membrane, the activation or in-
duction of a protease or nuclease, or the
irreversible inactivation of an enzyme. Cell
death caused by such changes can often be
detected by the irreversible destruction of
most cell functions or by the uptake of
basic dyes (trypan blue). A cell's ability to
multiply can also be destroyed by the irre-
versible reaction of molecules with DNA,
leading to chromosome breakage or to other
lethal modifications of the genetic material.
Such changes can usually not be detected by
functional tests of resting cells but only by
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cell's ability to replicate.
In an adult organism, the death of a few
cells usually has no observable effect, while
death of many cells in an organ will show
up as a toxic reaction. If the rate at which
an organ normally functions is not limited
by the number of its cells, a reduction of
this rate may show up only when the num-
ber of killed cells exceeds a certain thres-
hold value. Only a large extent of cell death
may therefore be registered as a toxic effect.
Different organs of the same organism are
consequently affected to different degrees by
the same frequency of cell death. Since dif-
ferent organisms, including different humans,
differ in their genetic constitution, they also
have different thresholds for organ failure
or for death.
An apparent threshold can result if the
compound can react with some cellular com-
ponents or be destroyed by some enzyme
before it reaches its target. A strong toxic
effect may then be observed only when the
concentration of the compound exceeds a
critical value above which the number of
reactive sites or the turnover of the destroy-
ing enzyme do not suffice to prevent the
accumulation of the inhibitor. This critical
value would not represent an absolute thres-
hold, because the effectiveness of the drug
would be only greatly reduced but not com-
pletely eliminated at lower inhibitor concen-
trations.
Teratogenic Effect
When a compound acts during early em-
bryogenesis (organogenesis), while the an-
lagen for different organs are laid down,
growth inhibition or death of a few cells can
drastically affect the relative ratio of dif-
ferentiated cells giving rise to an organ (14).
A teratogenic effect can therefore be pro-
duced by an inhibitory or lethal reaction of so
few cells that a toxic effect would not yet be
detectable in an adult organism. Moreover,
a low inhibitor concentration, which does
not restrict the function of resting cells or
adult organs, may already reduce the rate
at which certain embryonic cells replicate.
Similarly, a small number of killed cells,
which does not limit the function of an organ,
may already be disastrous for development.
The threshold (if any) for teratogenic effects
is presumably lower, therefore, than that
for toxic effects.
Mutagenic Effect
A mutation can be induced by the re-
action of one or two reagent molecules with
DNA. Such reactions can produce base pair
changes that lead to point mutations and
alter the functional properties of single
genes, or they can produce large chromo-
some alterations that affect several genes
or even whole chromosome segments. Muta-
genic effects are more insidious than toxic
effects, for a single mutated cell that multi-
plies can produce a massive effect in an or-
ganism. In comparison, the death of a single
cell is relatively harmless, except when it
occurs during early embryogenesis. If the
mutation affects a germinal cell, a dominant
or recessive hereditary disease or loss of
vitality may arise in the offspring; if it
alters an embryonic cell a malformation may
ensue; if it affects an adult cell, a tumor or
leukemia may develop (15).
Most direct mutagens react covalently with
DNA, are incorporated into DNA, or bind
quasi-irreversibly to DNA or its synthase.
All these reactions have been found to in-
crease linearly with the concentration of the
compound. There is apparently no intracel-
lular process by which a mutation can be
eliminated from a cell, once it has been
finalized in both strands of the double-
stranded DNA molecule.
If the mutated cell has an altered sur-
face, it can be recognized as a strange body
and be removed by phagocytosis or be coated
by circulating antibodies; such surface re-
cognition may in fact provide the major pro-
tection of higher organisms against a high
incidence of malignant growth (16). With-
out such surface changes, however, the
mutated cell can persist, and even with such
changes a fraction of mutated cells appar-
ently can occasionally replicate beyond the
stage at which antibodies or other cellular
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normal animals, more than one DNA altera-
tion per cell may be required to cause some
types of cancer, because the production of
pulmonary tumors in mice increased appro-
ximately with the square of the concentra-
tion of different alkylating chemicals (17).
The possibility that multiple mutations are
required for cancer had earlier been pro-
posed by Ashley (18). A statistical analysis
of retinoblastomas in humans also indicated
that two separate events (mutations) are
needed for the occurrence of most mono-
lateral cases; however, only one such event
is required for bilateral cases, the other muta-
tion apparently being inherited (19). Also,
radiation-induced leukemia and tumors in-
creased linearly with the dose (20). In any
case, neither for radiation nor for carcino-
gens that can react directly with DNA has
the dose dependence indicated the presence
of a threshold (17, 20, 21).
Nevertheless, an apparent or a true thres-
hold of mutation (or cancer) induction can
be expected to occur for a variety of reasons.
The frequency of such genetic effects in
different tissues is affected by the rates of
distribution, absorption, metabolism, and
excretion of the mutagen, each of which can
be influenced by genetic and environmental
factors. For example, an apparent threshold
concentration could be expected either if the
mutagen would be very effectively destroyed
before it could reach the nucleus (e.g., pero-
xides and other radical-producing compounds
are destroyed by peroxidase or catalase) or
if it would bind to, be taken up by, or other-
wise react with the cells close to the site
of administration, so that it could not reach
the germinal cells whose mutation alone
would be measured in certain tests. Only
rather high concentrations of a compound
might then show a strong mutagenic effect.
As another possibility, the activation or
destruction of the mutagen may require en-
zyme reactions that can be induced either
by the mutagen itself or by some other com-
pound. Since the importance of such enzyme
reactions (often microsomal enzymes) has
been realized, the correlation between muta-
gens and carcinogens has steadily increased
(15, 22, 23). The concentration or time
dependence of induction might then create
the impression of a threshold effect. The
extent of repair mechanisms in a cell also
influences the frequency of mutations; this
frequency differs in genetically different or-
ganisms. Such repair mechanisms may be
able to handle only a limited number of DNA
alterations and be overwhelmed by too high
concentrations of a mutagen, giving then
rise to a vast increase in mutation frequency.
A true threshold effect could be expected
for the few weak mutagens that inhibit
some enzyme needed to produce a precursor
of DNA; if that enzyme normally would
not limit the rate of DNA or chromosome
replication, the compound would be effective
only if its concentration exceeded a minimal
value.
Summary
The overall effect by which the reaction
of chemical or physical agents with cells in-
fluences an organism depends on the type of
reaction, the kind of cell, and the develop-
mental stage of the organism. Two major
factors have to be considered.
The inhibition or death of cells may have
drastic consequences for an afflicted cell,
but it influences an adult organism only if
it occurs in many cells. Such massive re-
actions produce toxic effects or, if they oc-
cur in germ cells, cause sterility. Only dur-
ing early development can the reactions of
a few cells be disastrous for the whole or-
ganism, e.g., if they produce malformations
(teratogenic effects). In contrast, the muta-
tion of a single cell can always have drastic
consequences for an organism, because if
the mutated cell replicates, it can produce
hereditary alterations, malformations, or
cancer.
When the affected cellular reactions do
not limit the rate at which the investigated
organ functions, there will be a threshold
concentration below which no functional de-
fect is produced. Such a threshold phenom-
enon occurs frequently for inhibitory or
lethal cell reactions, but both molecular con-
Environmental Health Perspectives 174siderations and experimental results show
that it is an exception for mutagenic altera-
tions.
Conclusion
If one wants to protect mankind adequ-
ately against mutations, one should extra-
polate mutagenic or carcinogenic effects,
observed at high doses of a compound, either
linearly or with some exponent of the con-
centration, if that can be established at
high doses (concentrations), to the spontan-
eous background effect of zero dose, unless
statistically significant measurements or
knowledge of the mutagenic mechanisms war-
rant otherwise. There is certainly no justifi-
cation to assume a positive no-effect (back-
ground only) dose for any mutagen or
carcinogen, except when the molecular mech-
anism by which the particular compound
induces mutations renders such a threshold
effect likely (e.g., if the mutations are pro-
duced by enzyme inhibition). Such a postu-
late is necessary, because mutagenic or
carcinogenic tests in mammals are expensive
and time-consuming, so that it is not feasible
to examine the mutagenic effect of many
compounds down to the low concentrations to
which mankind is exposed. It is also needed
as a minimum safety valve, because the
genetic and nutritional variation of people
and the influence of other environmental
compounds that act as activators or reducers
of a mutagenic effect can greatly influence
the mutagenicity or carcinogenicity of a
given compound. Society may decide that the
benefit of some compounds warrants a small
risk whose level can be set at a certain value,
as was done for x-radiation (20). Those who
then still advocate the widespread use of a
compound at a dose exceeding the accepted
risk level, because they claim the existence of
a threshold dose below which the compound
might be genetically ineffective, should be
obliged to prove their contention by statis-
tically significant measurements of the gene-
tic effects of the compound at the pro-
posed human dose in all usually employed
mammalian test systems.
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Discussion
Dr. R. B. Cummings (ORNL): I'd like to make
a comment about EMS reaching the target; it does
reach the target. If one looks at the ethylation of
DNA in sperm cells plotted against the admin-
istered dose interperitoneally, the effect is linear
with dose in a range from 400 to 50 mg/kg, and at
5 mg/kg it is only slightly off that linear extrapola-
tion downward. If one looks at ethylations/nucleotide
DNA extracted from the whole testes after the DNA
is cleaned up on a cesium chloride gradient, again
the ethylations per nucleotide follow a more complex
function but they follow it from a very high dose
down to 5 mg/kg. I don't really understand the
kinetics of that, but the point is that there is no
break in the effect; it gets in at high doses and low
doses, the function is smoothly continuous.
Dr. C. Kensler (Arthur D. Little, Inc.): You said
the basic guideline when you extrapolate downward
was linearly, unless one has evidence that that isn't
the case. What kind of evidence would you accept?
Dr. Freese: Statistically significant experimental
evidence showing the absence of a mutagenic effect
at low doses.
Dr. Kensler: You mean a 10,000 mouse experi-
ment.
Dr. Freese: Yes, that's exactly what I want to
say. Unless one has experimental evidence at low
doses, one has to extrapolate from the data obtained
at high doses. To do that one certainly should not
accept a threshold dose. There is a basic difference
between a mutagenic effect and a toxic effect. A
mutagenic effect alters single cells which then mul-
tiply; in a toxic effect a large number of cells must
be affected, by inhibition or cell killing before sig-
nificant toxicity is observed.
Dr. Kensler: One of the primary missions of the
NCTR was to set up a megamouse experiment to try
to tell the shape of the dose curve. Most people said
this would be a waste of time and money.
Dr. Freese: I'm not saying that one should do
it, but because it can't be done one has to extrapo-
late. One should not extrapolate to some assumed
no-effect value, but one should extrapolate linearly
down to zero dose.
Dr. Kensler: In our current status of ignorance
I'd like to see us investigate the lower end of the
dose curve, particularly for different kinds of
chemical mutagens.
Dr. Cummings: One more point with regard to
the Generoso data. I think that the data do not say
that there is a threshold. The data with regard to
dominant lethals simply say that you reach a point
at which it can no longer be measured. That's a
different thing; in fact, there is a positive effect with
regard to translocation at the lowest dose measured.
It would probably be possible to measure a translo-
cation frequency at even lower doses by doing a
larger experiment. The data really agree with your
interpretation.
Dr. Freese: Some of these issues are semantic.
The question is how you want to extrapolate
the data. You may decide that you want to
extrapolate the experimental curve down to that
dose which will give you a no-effect point or you
may decide to take the lowest experimental value
and extrapolate it linearly down to zero concentra-
tion, which will give some effect at any dose.
Dr. Cummings: Right. I don't know of any data
that would suggest that there is a real threshold.
Dr. J. F. Crow (Univ. of Wisconsin): I wanted
to reiterate Dr. Freese's point. When we say linear
extrapolation we don't really mean to fit a least-
squares line to the existing points and carry that
back as far as it goes. What we really mean is to
connect the existing points with the zero effect and
regard that as linear. Maybe we need a better
vocabulary.
Dr. B. Bridges (Univ. of Sussex): I think that
I would very much agree with what you say, that
you cannot assume that for genetic effects in a cell
there is a no-effect threshold. On the other hand, I
can see the toxicologist point of view-that the
substance may not reach the target organ. It seems
to me that we have a real problem here, in that
many environmental mutagens, two that I've worked
with, both mopped up pretty strongly in the body.
The concentration gradient from the route of entry
to the gonads can be very steep-so steep that I
doubt whether the pharmacologists can measure it-
and this makes it exceedingly difficult to do any
176 Environmental Health Perspectivescalculations. The toxicologists may believe firmly Dr. Freese: I think what we are trying to do is
that there is no mutagen in the gonads, and they to put the burden of proof upon those who argue
may be right. Certainly it will be quite clear that that there may be a threshold. To argue for a
there is less than a linear extrapolation back. It threshold with respect to a very small number of
seems to me this is really where we are going to reagent molecules is as meaningless as to state that
come across some major disagreements in the future. a chemical reaction requires a certain minimal
Dr. Freese: In that connection I would say that number of molecules if it is to take place. Whether
we are not only concerned about mutations in we can measure it or not, the chemical reaction still
gonads, impairing future generations, but also about occurs, and the reaction of individual molecules is
somatic mutations affecting the present generation. governed by statistical mechanisms.
If a compound is mutagenic we still don't want it in Dr. S. S. Epstein (Case Western Reserve): As
the population because we don't want a carcinogenic another card-car'ying toxicologist I'd like to make a
effect. couple of points. First of all I think it would be
Dr. L. Friedman (FDA): As probably the only helpful in situations like this to talk about apparent
card-carrying toxicologist present, when we start no-effect levels rather than no-effect levels. Toxicol-
talking about thresholds and no thresholds I think we ogists are very fond of calling these no-effect levels,
really are, in the present state of things, getting based on experiments of 30-40 mice or rats and from
into an area where we are not going to convince each such concepts of no-effect levels they proceed to
other by argumentation. I would like to make the equate no-effect levels with threshold. This clearly is
point that in considering a phenomenon such ap statistically nonsensical; it would be much simpler if
mutation in a very general respect, where, as you one talked about these as apparent no-effect levels to
point out, you are starting with a background level, make very clear the artifactual situation, namely:
you automatically have no possibility of demonstrat- a very small experiment of 30 or 40 animals com-
ing a threshold because you already are beyond a pared to millions or hundreds of millions of people
threshold, so the argument falls -right -there. The at risk.
issue, it seems to me, is not the general olne as to The second point I wanted to make, the mere fact
whether you see the threshold in a-general sense but that you have a natural background of environmen-
whether any particular substance you study which tal mutagens or carcinogens is not in any way
may or may not be out there in the environment is relevant to the concept of threshold. The fact that
contributing enough in itself to make a significant we have a background of environmental mutagen I
addition to background. When you begin to think presume has some relationship to mutagenesis in
about this kind of possibility, you must start from man and the adverse mutations and the high
a basic postulate and make some logical inferences incidence of cancers that man has suffered since
based on general knowledge. A-think we all agree time immorial. To suggest that the existence of a
the capability of doing exper-inens-a`t -su'ch low natural background of environmental carcinogens levels does not exist at the present- time. We can't and mutagens therefore brings the concept of
even think of measuring the doubling rate; we're not..
aboutthink ofmeasure/100 ofe1%uinc:rease-wes'menth threshold in the relationship to the introduction of about to measure 1/100 of 19% incerease,or';something nwsnhtcaet noteevrneti like that which would satisfy us-about a threshold new synthetic agents into the environment is a
phenomenon. But when you start to think--in these non-sequitur.
small numbers, the argument inevitably gets back -to Dr. S. Abrahamson (Univ. of Wisconsin): I
the smallest number to the one -molecule.- Your think Dr. Friedman was referring to a background
argument inevitably gets into that kind of a-frame-- mutation rate and not a background of environ-
work; then, to me at any rate, it -becomes -an mental mutagens, but perhaps Dr. Friedman would
intellectually repugnant concept that - you -.have -no like to rebut.
threshold, if you consider that a cell has-something Dr. Friedman: I'd like to clarify the issue a
like 10V2.1014 molecules and membranes,- structures- little. Toxicologists do not talk about no-effect levels.
and barriers of all kinds. The probability -of -- When they use the terminology it is always in the
molecule reaching whatever the target is becomes context of experimental no-effect levels. We don't
infinitely small even given an infinite time, so to talk
glibly about whether or not there is a threshold I
think serves nou .- sresults of a given experiment. In that case, the think serves no purpose. In the practical-.sense, I, exeiethssonan-fetlvlwt think, for mutation we've already- exceeded the
* * * ~~~ * * ~ certain degree of probability, and that's what we threshold; the issue in any particular case is what is tain d o b y t w
the evidence that we are actually- increasing- the talkabout
hazard. That's not such a simple matter, I know. We - Dr, Epstein: May I just make one point. This
tend to oversimplify and make things %ppear very conpept of no-effect level is equated in toxicological
easy by drawing these straight lines wherever -we circles to threshold levels. When you see a no-effect
decide we should draw them. This is -.another;- level in an experimental situation, that is proper in
question-where do we decide to draw them -fro..,- relation to that experimental situation. If you want
177 December 1973to extrapolate from that, talk about it as an answered this question yesterday when he asked
apparent no-effect level but don't get mixed up with what the effect is at those concentrations to which
thresholds. human beings are exposed and whether we can
Dr. Abrahamson: I really think that Dr. Bridges tolerate it if the agent is a valuable one.
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